Ricardo Pérez Alfonzo

Ricardo Pérez Alfonzo

Auto-generated profile, based on publicly available information

Ricardo Pérez Alfonzo

Servicio de Dermatología. Instituto de Biomedicina “Dr. Jacinto Convit”. Hospital Vargas de Caracas

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2021 in International Journal of Dermatology
Verified
Journal Article
Open access
PDF file
JOJorge Ocampo‐Candiani
Jorge Ocampo‐Candiani
CRCesar Jair Ramos‐Cavazos
Cesar Jair Ramos‐Cavazos
MAMaria Ivonne Arellano‐Mendoza
Maria Ivonne Arellano‐Mendoza
RARoberto Arenas
Roberto Arenas
ABAngélica Beirana‐Palencia
Angélica Beirana‐Palencia
RPRicardo Pérez‐Alfonzo
Ricardo Pérez‐Alfonzo
Background: The infection by coronavirus disease 2019 (COVID‐19) has been associated with multiple cutaneous manifestations, although characterization of them in Hispanic patients with darker skin phototypes is lacking. The objective of this study is to characterize the clinical dermatological manifestations associated with COVID‐19 infection in cases with few or without general symptoms in patients from Latin America.Methods: Cross‐sectional study using a questionnaire that was made for health professionals (physicians with a specialty in dermatology) to investigate dermatological lesions associated with COVID‐19 infection in patients from 25 countries of Latin America. The survey was active from June 9 to July 30, 2020.Results: In this study, information was collected from a total of 347 patients. We found a female gender predominance: 179/347 (51.6%). The mean age at presentation was 40.87 years. The most frequent dermatological manifestations were maculopapular rash and urticarial lesions, followed by papulovesicular lesions, vesicular lesions, chilblain‐like lesions, papular lesions, ecchymosis, petechial purpura, pityriasis rosea‐like lesions, pruritus, palmoplantar dysesthesias, transient livedo, acral necrosis, palpable purpura, livedo racemosa, and retiform purpura. As far as we know, there are no previous reports of pruritus and palmoplantar dysesthesias.Conclusions: This registry emphasizes skin manifestations as an important criterion for establishing the diagnosis of COVID‐19 infection in Latin American countries. This information will be useful for the early identification of suspected cases by health professionals (dermatologists and nondermatologists) and will allow contact tracing to mitigate the impact on health systems at different levels.

31 May 2026
Verified
Journal Article
Open access
PDF file
ADAndrea Cachutt Díaz
Andrea Cachutt Díaz
FFFrancisco Franco
Francisco Franco
RARicardo Pérez Alfonzo
Ricardo Pérez Alfonzo
EGElda Giansante
Elda Giansante
Las enfermedades autoinmunes del tejido conectivo como la morfea, esclerosis sistémica y el lupus cutáneo crónico se caracterizan por la presencia de atrofia, fibrosis, telangiectasias e hiperpigmentación, secuelas cosméticas que impactan psicosocialmente en la vida de los pacientes. Por ello se han descritos procedimientos dermocosméticos dirigidos a cada uno de estos procesos. Estos tratamientos deben cumplir con las pautas establecidas por el Colegio Americano de Reumatología ya que, la seguridad de estos procedimientos en pacientes con colagenopatías sigue en estudio. Es necesario el diseño de tratamientos reconstructivos para pacientes con enfermedades autoinmunes del tejido conectivo dadas las secuelas cosméticas potencialmente desfigurantes y su impacto en la calidad de vida. Autoimmune connective tissue diseases, such as morphea, systemic sclerosis, and chronic cutaneous lupus, are characterized by the presence of atrophy, fibrosis, telangiectasias, and yperpigmentation. These cosmetic sequelae have a significant psychosocial impact on patients' lives. Consequently, dermocosmetic procedures have been developed to address each of these processes. These treatments must comply with the guidelines established by the American College of Rheumatology since the safety of these procedures in patients with collagen diseases is still under study. Given the potentially disfiguring cosmetic sequelae and their impact on quality of life, the development of reconstructive treatments for patients with autoimmune connective tissue diseases is essential.